The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Atropine API Market Research Report 2025
Synopsis
Atropine is racemic hyoscyamine extracted from belladonna, datura and other plants of the same genus in the Solanaceae family. Its chemical formula is C17H23NO3. Its sulfate is a colorless crystal or white powder that is easily soluble in water. Atropine API is mainly used to prepare atropine drugs. Its main pharmacological effects are to block M choline receptors, relieve smooth muscle spasm (including relieving vasospasm and improving microvascular circulation), inhibit gland secretion, and relieve the inhibition of the vagus nerve on the heart. , speed up the heartbeat, dilate pupils, increase intraocular pressure, and excite the respiratory center. In addition, atropine can also excite or inhibit the central nervous system in a dose-dependent manner.
The global Atropine API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Atropine API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Atropine API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Atropine API include C2 Pharma, Katsura Chemical, HENAN PURUI, SAURAV CHEMICALS, ROLABO OUTSOURCING, Alchem International, Minsheng, RESONANCE LABORATORIES, Anant Labs, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Atropine API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atropine API.
The Atropine API market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Atropine API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Atropine API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
C2 Pharma
Katsura Chemical
HENAN PURUI
SAURAV CHEMICALS
ROLABO OUTSOURCING
Alchem International
Minsheng
RESONANCE LABORATORIES
Anant Labs
Segment by Type
Purity 98%
Purity 99%
Purity 99.9%
Others
Segment by Application
Gastrointestinal Drugs
Urinary System Drugs
Ophthalmic Drugs
Respiratory Medications
Cardiovascular Drugs
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Atropine API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Atropine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Atropine is racemic hyoscyamine extracted from belladonna, datura and other plants of the same genus in the Solanaceae family. Its chemical formula is C17H23NO3. Its sulfate is a colorless crystal or white powder that is easily soluble in water. Atropine API is mainly used to prepare atropine drugs. Its main pharmacological effects are to block M choline receptors, relieve smooth muscle spasm (including relieving vasospasm and improving microvascular circulation), inhibit gland secretion, and relieve the inhibition of the vagus nerve on the heart. , speed up the heartbeat, dilate pupils, increase intraocular pressure, and excite the respiratory center. In addition, atropine can also excite or inhibit the central nervous system in a dose-dependent manner.
The global Atropine API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Atropine API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Atropine API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Atropine API include C2 Pharma, Katsura Chemical, HENAN PURUI, SAURAV CHEMICALS, ROLABO OUTSOURCING, Alchem International, Minsheng, RESONANCE LABORATORIES, Anant Labs, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Atropine API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atropine API.
The Atropine API market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Atropine API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Atropine API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
C2 Pharma
Katsura Chemical
HENAN PURUI
SAURAV CHEMICALS
ROLABO OUTSOURCING
Alchem International
Minsheng
RESONANCE LABORATORIES
Anant Labs
Segment by Type
Purity 98%
Purity 99%
Purity 99.9%
Others
Segment by Application
Gastrointestinal Drugs
Urinary System Drugs
Ophthalmic Drugs
Respiratory Medications
Cardiovascular Drugs
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Atropine API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Atropine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Atropine API Market Overview
1.1 Product Definition
1.2 Atropine API by Type
1.2.1 Global Atropine API Market Value Comparison by Type (2024-2030)
1.2.2 Purity 98%
1.2.3 Purity 99%
1.2.4 Purity 99.9%
1.2.5 Others
1.3 Atropine API by Application
1.3.1 Global Atropine API Market Value by Application (2024-2030)
1.3.2 Gastrointestinal Drugs
1.3.3 Urinary System Drugs
1.3.4 Ophthalmic Drugs
1.3.5 Respiratory Medications
1.3.6 Cardiovascular Drugs
1.3.7 Others
1.4 Global Atropine API Market Size Estimates and Forecasts
1.4.1 Global Atropine API Revenue 2019-2030
1.4.2 Global Atropine API Sales 2019-2030
1.4.3 Global Atropine API Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Atropine API Market Competition by Manufacturers
2.1 Global Atropine API Sales Market Share by Manufacturers (2019-2024)
2.2 Global Atropine API Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Atropine API Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Atropine API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Atropine API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Atropine API, Product Type & Application
2.7 Global Key Manufacturers of Atropine API, Date of Enter into This Industry
2.8 Global Atropine API Market Competitive Situation and Trends
2.8.1 Global Atropine API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Atropine API Players Market Share by Revenue
2.8.3 Global Atropine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Atropine API Market Scenario by Region
3.1 Global Atropine API Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Atropine API Sales by Region: 2019-2030
3.2.1 Global Atropine API Sales by Region: 2019-2024
3.2.2 Global Atropine API Sales by Region: 2025-2030
3.3 Global Atropine API Revenue by Region: 2019-2030
3.3.1 Global Atropine API Revenue by Region: 2019-2024
3.3.2 Global Atropine API Revenue by Region: 2025-2030
3.4 North America Atropine API Market Facts & Figures by Country
3.4.1 North America Atropine API Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Atropine API Sales by Country (2019-2030)
3.4.3 North America Atropine API Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Atropine API Market Facts & Figures by Country
3.5.1 Europe Atropine API Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Atropine API Sales by Country (2019-2030)
3.5.3 Europe Atropine API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Atropine API Market Facts & Figures by Region
3.6.1 Asia Pacific Atropine API Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Atropine API Sales by Region (2019-2030)
3.6.3 Asia Pacific Atropine API Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Atropine API Market Facts & Figures by Country
3.7.1 Latin America Atropine API Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Atropine API Sales by Country (2019-2030)
3.7.3 Latin America Atropine API Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Atropine API Market Facts & Figures by Country
3.8.1 Middle East and Africa Atropine API Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Atropine API Sales by Country (2019-2030)
3.8.3 Middle East and Africa Atropine API Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Atropine API Sales by Type (2019-2030)
4.1.1 Global Atropine API Sales by Type (2019-2024)
4.1.2 Global Atropine API Sales by Type (2025-2030)
4.1.3 Global Atropine API Sales Market Share by Type (2019-2030)
4.2 Global Atropine API Revenue by Type (2019-2030)
4.2.1 Global Atropine API Revenue by Type (2019-2024)
4.2.2 Global Atropine API Revenue by Type (2025-2030)
4.2.3 Global Atropine API Revenue Market Share by Type (2019-2030)
4.3 Global Atropine API Price by Type (2019-2030)
5 Segment by Application
5.1 Global Atropine API Sales by Application (2019-2030)
5.1.1 Global Atropine API Sales by Application (2019-2024)
5.1.2 Global Atropine API Sales by Application (2025-2030)
5.1.3 Global Atropine API Sales Market Share by Application (2019-2030)
5.2 Global Atropine API Revenue by Application (2019-2030)
5.2.1 Global Atropine API Revenue by Application (2019-2024)
5.2.2 Global Atropine API Revenue by Application (2025-2030)
5.2.3 Global Atropine API Revenue Market Share by Application (2019-2030)
5.3 Global Atropine API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 C2 Pharma
6.1.1 C2 Pharma Company Information
6.1.2 C2 Pharma Description and Business Overview
6.1.3 C2 Pharma Atropine API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 C2 Pharma Atropine API Product Portfolio
6.1.5 C2 Pharma Recent Developments/Updates
6.2 Katsura Chemical
6.2.1 Katsura Chemical Company Information
6.2.2 Katsura Chemical Description and Business Overview
6.2.3 Katsura Chemical Atropine API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Katsura Chemical Atropine API Product Portfolio
6.2.5 Katsura Chemical Recent Developments/Updates
6.3 HENAN PURUI
6.3.1 HENAN PURUI Company Information
6.3.2 HENAN PURUI Description and Business Overview
6.3.3 HENAN PURUI Atropine API Sales, Revenue and Gross Margin (2019-2024)
6.3.4 HENAN PURUI Atropine API Product Portfolio
6.3.5 HENAN PURUI Recent Developments/Updates
6.4 SAURAV CHEMICALS
6.4.1 SAURAV CHEMICALS Company Information
6.4.2 SAURAV CHEMICALS Description and Business Overview
6.4.3 SAURAV CHEMICALS Atropine API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 SAURAV CHEMICALS Atropine API Product Portfolio
6.4.5 SAURAV CHEMICALS Recent Developments/Updates
6.5 ROLABO OUTSOURCING
6.5.1 ROLABO OUTSOURCING Company Information
6.5.2 ROLABO OUTSOURCING Description and Business Overview
6.5.3 ROLABO OUTSOURCING Atropine API Sales, Revenue and Gross Margin (2019-2024)
6.5.4 ROLABO OUTSOURCING Atropine API Product Portfolio
6.5.5 ROLABO OUTSOURCING Recent Developments/Updates
6.6 Alchem International
6.6.1 Alchem International Company Information
6.6.2 Alchem International Description and Business Overview
6.6.3 Alchem International Atropine API Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Alchem International Atropine API Product Portfolio
6.6.5 Alchem International Recent Developments/Updates
6.7 Minsheng
6.7.1 Minsheng Company Information
6.7.2 Minsheng Description and Business Overview
6.7.3 Minsheng Atropine API Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Minsheng Atropine API Product Portfolio
6.7.5 Minsheng Recent Developments/Updates
6.8 RESONANCE LABORATORIES
6.8.1 RESONANCE LABORATORIES Company Information
6.8.2 RESONANCE LABORATORIES Description and Business Overview
6.8.3 RESONANCE LABORATORIES Atropine API Sales, Revenue and Gross Margin (2019-2024)
6.8.4 RESONANCE LABORATORIES Atropine API Product Portfolio
6.8.5 RESONANCE LABORATORIES Recent Developments/Updates
6.9 Anant Labs
6.9.1 Anant Labs Company Information
6.9.2 Anant Labs Description and Business Overview
6.9.3 Anant Labs Atropine API Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Anant Labs Atropine API Product Portfolio
6.9.5 Anant Labs Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Atropine API Industry Chain Analysis
7.2 Atropine API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Atropine API Production Mode & Process
7.4 Atropine API Sales and Marketing
7.4.1 Atropine API Sales Channels
7.4.2 Atropine API Distributors
7.5 Atropine API Customers
8 Atropine API Market Dynamics
8.1 Atropine API Industry Trends
8.2 Atropine API Market Drivers
8.3 Atropine API Market Challenges
8.4 Atropine API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Atropine API Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Atropine API Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Atropine API Market Competitive Situation by Manufacturers in 2023
Table 4. Global Atropine API Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Atropine API Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Atropine API Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Atropine API Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Atropine API Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Atropine API, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Atropine API, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Atropine API, Product Type & Application
Table 12. Global Key Manufacturers of Atropine API, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Atropine API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atropine API as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Atropine API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Atropine API Sales by Region (2019-2024) & (K Units)
Table 18. Global Atropine API Sales Market Share by Region (2019-2024)
Table 19. Global Atropine API Sales by Region (2025-2030) & (K Units)
Table 20. Global Atropine API Sales Market Share by Region (2025-2030)
Table 21. Global Atropine API Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Atropine API Revenue Market Share by Region (2019-2024)
Table 23. Global Atropine API Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Atropine API Revenue Market Share by Region (2025-2030)
Table 25. North America Atropine API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Atropine API Sales by Country (2019-2024) & (K Units)
Table 27. North America Atropine API Sales by Country (2025-2030) & (K Units)
Table 28. North America Atropine API Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Atropine API Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Atropine API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Atropine API Sales by Country (2019-2024) & (K Units)
Table 32. Europe Atropine API Sales by Country (2025-2030) & (K Units)
Table 33. Europe Atropine API Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Atropine API Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Atropine API Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Atropine API Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Atropine API Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Atropine API Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Atropine API Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Atropine API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Atropine API Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Atropine API Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Atropine API Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Atropine API Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Atropine API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Atropine API Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Atropine API Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Atropine API Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Atropine API Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Atropine API Sales (K Units) by Type (2019-2024)
Table 51. Global Atropine API Sales (K Units) by Type (2025-2030)
Table 52. Global Atropine API Sales Market Share by Type (2019-2024)
Table 53. Global Atropine API Sales Market Share by Type (2025-2030)
Table 54. Global Atropine API Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Atropine API Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Atropine API Revenue Market Share by Type (2019-2024)
Table 57. Global Atropine API Revenue Market Share by Type (2025-2030)
Table 58. Global Atropine API Price (US$/Unit) by Type (2019-2024)
Table 59. Global Atropine API Price (US$/Unit) by Type (2025-2030)
Table 60. Global Atropine API Sales (K Units) by Application (2019-2024)
Table 61. Global Atropine API Sales (K Units) by Application (2025-2030)
Table 62. Global Atropine API Sales Market Share by Application (2019-2024)
Table 63. Global Atropine API Sales Market Share by Application (2025-2030)
Table 64. Global Atropine API Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Atropine API Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Atropine API Revenue Market Share by Application (2019-2024)
Table 67. Global Atropine API Revenue Market Share by Application (2025-2030)
Table 68. Global Atropine API Price (US$/Unit) by Application (2019-2024)
Table 69. Global Atropine API Price (US$/Unit) by Application (2025-2030)
Table 70. C2 Pharma Company Information
Table 71. C2 Pharma Description and Business Overview
Table 72. C2 Pharma Atropine API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. C2 Pharma Atropine API Product
Table 74. C2 Pharma Recent Developments/Updates
Table 75. Katsura Chemical Company Information
Table 76. Katsura Chemical Description and Business Overview
Table 77. Katsura Chemical Atropine API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Katsura Chemical Atropine API Product
Table 79. Katsura Chemical Recent Developments/Updates
Table 80. HENAN PURUI Company Information
Table 81. HENAN PURUI Description and Business Overview
Table 82. HENAN PURUI Atropine API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. HENAN PURUI Atropine API Product
Table 84. HENAN PURUI Recent Developments/Updates
Table 85. SAURAV CHEMICALS Company Information
Table 86. SAURAV CHEMICALS Description and Business Overview
Table 87. SAURAV CHEMICALS Atropine API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. SAURAV CHEMICALS Atropine API Product
Table 89. SAURAV CHEMICALS Recent Developments/Updates
Table 90. ROLABO OUTSOURCING Company Information
Table 91. ROLABO OUTSOURCING Description and Business Overview
Table 92. ROLABO OUTSOURCING Atropine API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. ROLABO OUTSOURCING Atropine API Product
Table 94. ROLABO OUTSOURCING Recent Developments/Updates
Table 95. Alchem International Company Information
Table 96. Alchem International Description and Business Overview
Table 97. Alchem International Atropine API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Alchem International Atropine API Product
Table 99. Alchem International Recent Developments/Updates
Table 100. Minsheng Company Information
Table 101. Minsheng Description and Business Overview
Table 102. Minsheng Atropine API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Minsheng Atropine API Product
Table 104. Minsheng Recent Developments/Updates
Table 105. RESONANCE LABORATORIES Company Information
Table 106. RESONANCE LABORATORIES Description and Business Overview
Table 107. RESONANCE LABORATORIES Atropine API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. RESONANCE LABORATORIES Atropine API Product
Table 109. RESONANCE LABORATORIES Recent Developments/Updates
Table 110. Anant Labs Company Information
Table 111. Anant Labs Description and Business Overview
Table 112. Anant Labs Atropine API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Anant Labs Atropine API Product
Table 114. Anant Labs Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Atropine API Distributors List
Table 118. Atropine API Customers List
Table 119. Atropine API Market Trends
Table 120. Atropine API Market Drivers
Table 121. Atropine API Market Challenges
Table 122. Atropine API Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Atropine API
Figure 2. Global Atropine API Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Atropine API Market Share by Type: 2023 & 2030
Figure 4. Purity 98% Product Picture
Figure 5. Purity 99% Product Picture
Figure 6. Purity 99.9% Product Picture
Figure 7. Others Product Picture
Figure 8. Global Atropine API Market Value by Application (2024-2030) & (US$ Million)
Figure 9. Global Atropine API Market Share by Application: 2023 & 2030
Figure 10. Gastrointestinal Drugs
Figure 11. Urinary System Drugs
Figure 12. Ophthalmic Drugs
Figure 13. Respiratory Medications
Figure 14. Cardiovascular Drugs
Figure 15. Others
Figure 16. Global Atropine API Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Atropine API Market Size (2019-2030) & (US$ Million)
Figure 18. Global Atropine API Sales (2019-2030) & (K Units)
Figure 19. Global Atropine API Average Price (US$/Unit) & (2019-2030)
Figure 20. Atropine API Report Years Considered
Figure 21. Atropine API Sales Share by Manufacturers in 2023
Figure 22. Global Atropine API Revenue Share by Manufacturers in 2023
Figure 23. Global 5 and 10 Largest Atropine API Players: Market Share by Revenue in Atropine API in 2023
Figure 24. Atropine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 25. Global Atropine API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 26. North America Atropine API Sales Market Share by Country (2019-2030)
Figure 27. North America Atropine API Revenue Market Share by Country (2019-2030)
Figure 28. United States Atropine API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Canada Atropine API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Europe Atropine API Sales Market Share by Country (2019-2030)
Figure 31. Europe Atropine API Revenue Market Share by Country (2019-2030)
Figure 32. Germany Atropine API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. France Atropine API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. U.K. Atropine API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Italy Atropine API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Russia Atropine API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Atropine API Sales Market Share by Region (2019-2030)
Figure 38. Asia Pacific Atropine API Revenue Market Share by Region (2019-2030)
Figure 39. China Atropine API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Japan Atropine API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. South Korea Atropine API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. India Atropine API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Australia Atropine API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. China Taiwan Atropine API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Atropine API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Atropine API Sales Market Share by Country (2019-2030)
Figure 47. Mexico Atropine API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Atropine API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Atropine API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Colombia Atropine API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East and Africa Atropine API Sales Market Share by Country (2019-2030)
Figure 52. Middle East and Africa Atropine API Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Atropine API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Atropine API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Atropine API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Atropine API by Type (2019-2030)
Figure 57. Global Revenue Market Share of Atropine API by Type (2019-2030)
Figure 58. Global Atropine API Price (US$/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Atropine API by Application (2019-2030)
Figure 60. Global Revenue Market Share of Atropine API by Application (2019-2030)
Figure 61. Global Atropine API Price (US$/Unit) by Application (2019-2030)
Figure 62. Atropine API Value Chain
Figure 63. Atropine API Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
